Breadcrumb Home Machine Learning for Health (ML4H) ML4H Team Meet our diverse and collaborative team of investigators, engineers, clinicians, and students. Together, we drive innovation in machine learning for health. Principal Investigators Patrick Ellinor, M.D., Ph.D.Mahnaz Maddah, Ph.D.Chris Anderson, M.D., M.M.Sc.Jennifer E. Ho, M.D.Judy Hung, M.D.Caroline Uhler, Ph.D.Marzyeh Ghassemi, Ph.D.Martha Gray, Ph.D.Jason Buenrostro, Ph.D.Konrad Karczewski, Ph.D.Sam Friedman, Ph.DShaan Khurshid, M.D.Collin Stultz, M.D., Ph.D. Director Mahnaz Maddah, Ph.D. AI/ML Leads Sam Friedman, Ph.D.Danielle Pace, Ph.D.Tal Shnitzer, Ph.D.Valentina D'Souza, M.Sc.Deepak Nelapatla, M.Sc.Arash Nargesi, M.D., M.P.H.Mostafa Al-Alusi, M.D., M.Sc.Sana Tonekaboni, Ph.D.Lena Stempfle, Ph.D.Erik Holbrook, M.D. MLOps Engineers John Kitonyo, M.Sc.Rakesh Rathod, M.Sc. AI/ML Students Zack Berger - MIT PhD CandidateAndri Kadaifciu - Duke Univ.Setareh Khakifirooz - Northeastern Univ.Majd Alafrang - MIT UROP Aleena Iraqui - Northeastern Univ. Irith Katiyar - Harvard Medical School Clinical Leads and Collaborators Steve Atlas, M.D.Emily Lau, M.D.Victor Nauffal, M.D.Akl C. Fahed, M.D.Alaleh Azhir, M.D.Joel Ramo, M.D.Jon Cunningham, M.D.Julian Haimovich, M.D.Shino Kany, M.D.Rahul Mahajan, M.D.Min Seo Kim, M.D. M.Sc. Project Manager Erin Schoenbeck ML4H Overview Team Collaborations Key projects Clinical AI Seminar Series Publications Latest news News 08.10.2026 New effort launches at Broad to accelerate translation of genetics to therapies News 08.05.2026 Cancer Dependency Map now includes next-generation 3D cancer models News 07.23.2026 Combining AI with laboratory evolution yields improved proteins News 07.21.2026 Broad Institute, Boston Children’s Hospital, and The Jackson Laboratory launch the Center for Therapeutic Genetics, a non-profit effort to develop genetic medicines for rare and ultra-rare diseases All news
News 07.21.2026 Broad Institute, Boston Children’s Hospital, and The Jackson Laboratory launch the Center for Therapeutic Genetics, a non-profit effort to develop genetic medicines for rare and ultra-rare diseases